India Oxygen Concentrators Market Outlook to 2035

The report titled “India Oxygen Concentrators Market Outlook to 2035 – By Product Type, By Technology Type, By Flow Rate, By Distribution Channel, By End-User, and By Region” provides a comprehensive analysis of the oxygen concentrators industry in India. The report covers an overview and genesis of the market, overall market size in terms of value, detailed market segmentation; trends and developments, regulatory and compliance landscape, patient and provider-level profiling, key issues and challenges, and competitive landscape including competition scenario, cross-comparison, opportunities and bottlenecks, and company profiling of major players in the India oxygen concentrators market. The report concludes with future market projections based on chronic respiratory disease burden, aging population, home healthcare expansion, hospital oxygen infrastructure planning, procurement modernization, device penetration rates across tier-2/3 cities, e-commerce and retail channel expansion, cause-and-effect relationships, and success case studies highlighting the major opportunities and cautions.

India Oxygen Concentrators Market Overview and Size

The India oxygen concentrators market is valued at ~USD ~ billion (i.e. ~USD ~ billion). This reflects the combined demand for stationary/home oxygen concentrators, portable oxygen concentrators (POCs), and high-flow concentrator systems deployed across homecare, hospitals, emergency response settings, and long-term care environments. The market is anchored by India’s high prevalence of chronic respiratory conditions such as COPD and asthma, rising post-acute respiratory care needs, expanding ICU and respiratory care capacity, and increasing preference for home-based therapy for stable long-term oxygen therapy (LTOT) patients. Demand has also been structurally influenced by heightened awareness of oxygen therapy and preparedness following pandemic-era oxygen shortages, which accelerated adoption of concentrators as an oxygen source alternative to cylinders in select use cases.

Maharashtra, Delhi-NCR, Karnataka, Tamil Nadu, and Gujarat dominate the India oxygen concentrators market, supported by higher hospital density, stronger private healthcare participation, higher homecare adoption, and better availability of medical device distribution networks. Tier-1 metros lead due to the concentration of pulmonology and critical care services, higher diagnosis rates of chronic respiratory illness, and greater affordability for home oxygen devices. Tier-2 and tier-3 cities are witnessing rising demand driven by increasing incidence of lifestyle-related respiratory conditions, better diagnostic reach through private clinics, and improving last-mile distribution via e-commerce and pharmacy chains. Rural markets remain underpenetrated but show gradual adoption as home healthcare players expand service coverage and as state-level procurement improves access in district hospitals. The market exhibits recurring demand characteristics as devices require accessories and periodic servicing, and as homecare users upgrade from basic stationary units to lighter portable devices depending on mobility needs and income progression.

What Factors are Leading to the Growth of the India Oxygen Concentrators Market:

High and rising burden of chronic respiratory disease strengthens long-term oxygen therapy demand.:

India carries a large and growing base of patients with chronic respiratory conditions, including COPD, asthma, pulmonary fibrosis, and post-TB lung complications. A significant cohort of these patients progresses to a stage where long-term oxygen therapy is clinically recommended to manage hypoxemia, reduce hospitalizations, and improve quality of life. As diagnosis improves through increased spirometry use, pulse oximetry availability, and specialist consultations, more patients enter the oxygen therapy funnel. This enlarges the addressable market for home oxygen concentrators and supports stable, recurring demand rather than one-time episodic purchases. In addition, air pollution exposure and smoking prevalence in certain pockets contribute to ongoing incidence and disease progression, sustaining the long-term requirement for oxygen support solutions.

Expansion of home healthcare and preference for home-based respiratory therapy accelerates adoption.:

Homecare is increasingly preferred for stable chronic respiratory patients, elderly individuals with mobility constraints, and families seeking to reduce repeated hospital visits. Oxygen concentrators enable continuous oxygen supply without the recurring logistics of cylinder refills, making them more convenient for long-duration usage where clinical flow requirements fit concentrator capability. Home healthcare providers and DME (durable medical equipment) players increasingly offer home oxygen packages combining concentrator rental/sale, accessories, pulse oximeters, and periodic servicing. This “service wrap” improves patient confidence and reduces friction in device adoption. The shift also aligns with broader healthcare cost optimization as home therapy can reduce hospitalization days and lower out-of-pocket medical spending for families over time.

Distribution expansion through pharmacy chains, e-commerce, and localized medical device retail improves access.:

India’s oxygen concentrator market has benefited from widened distribution beyond traditional hospital-linked suppliers. Retail pharmacy chains, online marketplaces, and specialized homecare stores have improved availability, price visibility, and doorstep delivery, enabling faster adoption in non-metro cities. Digital channels also support product comparisons, user reviews, financing options, and customer support requests, reducing purchase hesitation among families. As online medical commerce becomes more trusted for devices and accessories, portable concentrators and smaller stationary devices see higher adoption through consumer-driven channels. This distribution expansion increases market penetration and supports growth even in regions where specialist access is limited.

Which Industry Challenges Have Impacted the Growth of the India Oxygen Concentrators Market:

Power reliability, maintenance quality, and service network gaps affect user experience and trust:

Concentrators rely on stable electricity supply, and performance can be affected by voltage fluctuations, power cuts, and high ambient temperature/dust conditions if maintenance is weak. In many regions, users face challenges related to filter replacement, servicing delays, lack of trained technicians, and inadequate guidance on device operation. Poor service experiences can increase device downtime and lead families to revert to cylinders or reduce therapy adherence. Maintenance complexity becomes more pronounced in tier-2/3 cities where authorized service centers may be limited. This creates an advantage for brands and distributors that provide strong after-sales support, but it also increases operational costs for providers and adds friction to market expansion.

Product quality variability and non-standardized sourcing create buyer confusion:

The market has seen periods of rapid demand spikes, which can attract low-quality imports and non-standardized products sold through unorganized channels. Buyers often struggle to evaluate performance reliability, oxygen concentration stability, warranty terms, and true suitability for clinical needs. Variability in product quality can reduce trust and increase the risk of device failure, especially when devices are purchased without adequate clinical guidance. Hospitals and homecare providers increasingly demand performance documentation and stronger warranty/service terms, while consumers rely on brand trust and channel credibility. This quality variability challenges market stability and pushes organized players to invest in education, channel control, and quality assurance.

Therapy adherence and clinical follow-up challenges reduce sustained usage in home settings:

Even when a concentrator is purchased, adherence to oxygen therapy can be inconsistent due to discomfort, perceived dependency, lack of counseling, or improper flow prescription. Some patients use oxygen only when symptomatic rather than as clinically advised, reducing the perceived benefit and weakening long-term device value. Families may also underutilize devices due to concerns about electricity cost, noise, or fear of complications. Limited structured follow-up and patient education in many care pathways contributes to this issue. As a result, market growth is partly constrained by the gap between device adoption and sustained therapy adherence, creating a need for better patient onboarding, remote monitoring, and clinician engagement.

What are the Regulations and Initiatives which have Governed the Market:

Medical device quality, safety, and registration requirements shape product compliance:

Oxygen concentrators fall within the medical device ecosystem and are expected to comply with applicable quality management systems, labeling requirements, and safety standards aligned with medical electrical equipment norms. As compliance expectations increase, organized importers and domestic manufacturers invest in documentation, testing, warranty structures, and traceability. Hospitals and institutional buyers increasingly evaluate vendors on compliance readiness, service capability, and product reliability. This improves overall market quality over time but can increase cost burdens for smaller vendors and reduce the viability of unorganized supply, especially for institutional tenders that require strong documentation.

Public procurement, emergency preparedness, and hospital oxygen strengthening initiatives influence demand:

Government-led procurement and hospital oxygen strengthening programs have influenced demand patterns, especially in district hospitals and public health facilities. Procurement often emphasizes availability, durability, service support, and deployment speed. Concentrators are frequently positioned as part of resilience planning, step-down care infrastructure, and backup oxygen support for smaller facilities. Over time, procurement processes are becoming more structured, with greater emphasis on vendor capability, service response terms, and standardized technical specifications, which benefits organized players and improves long-term device utilization outcomes in public facilities.

Data privacy and telehealth-linked monitoring expectations emerge with connected homecare models:

While oxygen concentrators are not universally connected devices, homecare providers increasingly offer remote support models that may involve patient monitoring, pulse oximetry tracking, call-center follow-ups, and digital service logs. As digital health expands, expectations around consent, data handling, and secure storage become more relevant, particularly when providers integrate patient records with homecare management systems. Institutional buyers and organized homecare players increasingly emphasize secure processes and audit readiness. This trend adds operational complexity but also enables scalable patient engagement and improved therapy adherence through structured follow-up.

India Oxygen Concentrators Market Segmentation

By Product Type: Stationary/Home Oxygen Concentrators hold dominance.

This is because stationary concentrators are the preferred choice for long-term oxygen therapy in home settings and for low-to-moderate flow requirements in smaller healthcare facilities. These devices offer continuous operation, stable performance for prescribed flow ranges, and lower cost compared to portable concentrators. They are commonly used by elderly COPD patients, post-acute respiratory recovery cohorts, and patients requiring daily oxygen support at home. Portable oxygen concentrators are expanding due to mobility needs and rising affordability in select segments, but their higher price and battery limitations constrain mass adoption. High-flow concentrators remain niche, primarily deployed in clinical settings where higher oxygen output is required and where system redundancy is planned.

Stationary / Home Oxygen Concentrators  ~62 %
Portable Oxygen Concentrators (POCs)  ~26 %
High-Flow / Clinical Grade Concentrators  ~12 %

By End-User: Homecare dominates the India oxygen concentrators market.

Homecare accounts for the largest share as long-term oxygen therapy patients increasingly prefer continuous home usage, supported by family caregivers, homecare providers, and DME suppliers. Hospitals represent a significant share through ward-level support, step-down care, and emergency preparedness stock, while smaller clinics and nursing homes use concentrators to reduce cylinder dependence for basic oxygen needs. Public facilities contribute through procurement cycles, especially where oxygen infrastructure strengthening is a priority. The shift toward home management of chronic diseases further strengthens homecare dominance.

Homecare / Individual Patients  ~58 %
Hospitals (Private + Public)  ~24 %
Clinics, Nursing Homes & Small Healthcare Facilities  ~12 %
Emergency Response, Ambulance, and Community Health Settings  ~6 %

Competitive Landscape in India Oxygen Concentrators Market

The India oxygen concentrators market exhibits moderate concentration, led by global medical device manufacturers and specialized oxygen therapy brands with established distribution networks and service ecosystems. Market leadership is driven by product reliability, oxygen purity stability, warranty and after-sales support, availability of spare parts and consumables, and channel reach across hospitals and homecare markets. International brands dominate premium portable concentrators and high-reliability stationary devices, while domestic manufacturers and assemblers compete through pricing, faster supply, and localized service networks. Organized players increasingly differentiate through stronger service coverage, preventive maintenance packages, rental programs, and partnerships with homecare providers and hospital groups, while smaller traders compete on price through unorganized supply channels.

Some of the Recent Competitor Trends and Key Information About Competitors Include:

Philips (Oxygen Therapy / Respiratory Care): Philips maintains strong relevance in hospital-led respiratory care ecosystems through its broader respiratory portfolio and established channel relationships. In the concentrator segment, brand strength is supported by clinician trust, structured service programs, and integration with respiratory care pathways. Its presence is reinforced where hospitals and organized homecare providers prioritize reliability, warranty, and service responsiveness.

Inogen: Inogen is widely associated with portable oxygen concentrators and mobility-led oxygen therapy. The brand’s positioning benefits from demand among active users, travel needs, and patients seeking lifestyle-friendly therapy. Inogen-style devices typically compete on weight, battery options, noise, and ease of carrying, with adoption concentrated in higher-income cohorts and in metro-driven private healthcare channels.

Drive DeVilbiss Healthcare and Invacare: These brands are recognized for stationary concentrator reliability and durable performance in long-duration usage environments. Their products often compete strongly in homecare and institutional settings where continuous operation, serviceability, and spare parts availability are central purchase criteria. Their market strength is reinforced through DME distributors and respiratory equipment dealers with service technician coverage.

Owgels and value-focused import brands: Value-focused brands continue to scale in India through affordability-driven channels, particularly in tier-2/3 markets. Their growth is often supported by broad distributor networks and availability across e-commerce and retail outlets. However, competitive differentiation increasingly depends on warranty clarity, service coverage, and demonstrated performance consistency, especially as buyer awareness rises.

Indian players and localized assemblers: Domestic players and assemblers compete through price competitiveness, faster delivery, and improving service footprints. Growth strategies often include partnerships with hospital procurement channels, government tenders, and homecare providers offering rental and service bundles. Over time, domestic players aim to improve credibility through better quality systems, service readiness, and standardized product documentation.

What Lies Ahead for India Oxygen Concentrators Market?

The India Oxygen Concentrators Market is expected to expand steadily by 2035, supported by rising chronic respiratory disease burden, increasing diagnosis and therapy initiation, expanding home healthcare penetration, and strengthening of oxygen preparedness infrastructure across hospitals and public health facilities. Growth momentum is reinforced by India’s aging population, increasing air pollution exposure, rising post-acute respiratory care demand, and an evolving preference for home-based management of chronic conditions. Advancements in concentrator efficiency, noise reduction, portability, battery performance, and service models are shaping the next phase of market evolution, strengthening oxygen concentrators as a core component of respiratory care delivery.

Transition Toward Home-Based Long-Term Oxygen Therapy and Structured Homecare Packages:

The future of India’s concentrator market will be increasingly homecare-led, as families and clinicians shift stable chronic patients from frequent hospital dependence toward long-term home therapy. Homecare providers and DME players will increasingly bundle devices with accessories, servicing, caregiver training, and periodic check-ins. This bundled approach improves therapy adherence, reduces device downtime, and builds trust, thereby increasing conversion and retention. Rental and subscription-like access models are expected to grow, especially for post-acute patients requiring oxygen support for limited durations, enabling affordability and faster access without high upfront costs.

Growing Adoption of Portable Oxygen Concentrators Driven by Mobility and Lifestyle Needs:

Portable oxygen concentrators are likely to gain share as device prices gradually become more accessible and as patient expectations evolve toward mobility-friendly therapy. Adoption will be strongest among urban patients, working professionals, and travel-oriented users who require oxygen therapy without being confined to home. Product differentiation will increasingly center on weight, battery life, fast charging, noise reduction, oxygen delivery modes, and service coverage. Over time, portability improvements and financing availability can expand the addressable market beyond premium segments.

Strengthening of Public Health Facility Preparedness and District-Level Oxygen Resilience:

Public procurement and hospital strengthening programs are expected to support incremental demand for concentrators in district hospitals, community health centers, and smaller healthcare facilities. Concentrators will remain complementary to broader oxygen infrastructure such as PSA plants and LMO systems, serving as localized backup, ward-level support, and step-down care equipment. Procurement frameworks are likely to become more standardized, emphasizing service support and performance stability. This creates long-term opportunities for suppliers that can provide nationwide service networks and compliance-ready documentation.

India Oxygen Concentrators Market Segmentation

By Product Type

• Stationary / Home Oxygen Concentrators
• Portable Oxygen Concentrators (POCs)
• High-Flow / Clinical Grade Concentrators

By Technology Type

• Continuous Flow Concentrators
• Pulse Dose Concentrators
• Hybrid Models (Dual-mode: Continuous + Pulse)

By Flow Rate

• 1–5 LPM (Low Flow)
• 5–10 LPM (Mid Flow)
• 10+ LPM (High Flow / Clinical)

By Distribution Channel

• Hospitals & Institutional Procurement
• Durable Medical Equipment (DME) Dealers / Homecare Suppliers
• Pharmacies & Medical Retail Stores
• Online / E-commerce Platforms
• Government Procurement / Public Health Supply Channels

By End-User

• Homecare / Individual Patients
• Hospitals (Private + Public)
• Clinics, Nursing Homes & Small Healthcare Facilities
• Emergency Response / Ambulance / Community Health

By Region

• North India
• West India
• South India
• East India
• Central India
• North-East India

Players Mentioned in the Report:

• Philips (Respiratory Care / Oxygen Therapy)
• ResMed (Respiratory Care Ecosystem)
• Invacare
• Drive DeVilbiss Healthcare
• Inogen
• CAIRE Inc.
• Nidek Medical
• Owgels
• Oxymed (India)
• Other domestic manufacturers, DME distributors, homecare providers, and regional medical device dealers

Key Target Audience

• Entities that are likely buyers/users of this market report include:
• Oxygen concentrator manufacturers and component suppliers
• Importers, distributors, and durable medical equipment (DME) dealers
• Home healthcare service providers and respiratory care clinics
• Hospitals and integrated healthcare systems (public and private)
• Government health departments and public procurement bodies
• E-commerce and pharmacy chains expanding medical devices
• Healthcare-focused private equity and investment stakeholders
• Insurance and payer stakeholders exploring homecare coverage models
• NGOs and disaster preparedness organizations supporting emergency oxygen readiness

Time Period:

Historical Period: 2019–2024
Base Year: 2025
Forecast Period: 2025–2035